MODULATION OF IMMUNE FUNCTION OCCURS WITHIN HOURS OF THERAPY INITIATION FOR MULTIPLE SCLEROSIS

Daily administration of FDA-approved glatiramer acetate (GA) has beneficial effects on clinical course of relapsing remitting multiple sclerosis (RRMS). Although mechanisms of GA-action have been widely investigated and partially understood, immediate immune dynamics following GA-therapy are unknown...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ayers, Chris L., Mendoza, Jason P., Sinha, Sushmita, Cunnusamy, Khrishen, Greenberg, Benjamin M., Frohman, Elliot M., Karandikar, Nitin J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2013
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3634883/
https://ncbi.nlm.nih.gov/pubmed/23578552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2013.02.015
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge